Clinical trial
Elimination of Albumin-Bound Substances by MARS and Prometheus
NCT00407004 · Medical University of Graz, Other · Completed
Key facts
| NCT number | NCT00407004 |
|---|---|
| Title | Elimination of Albumin-Bound Substances by MARS and Prometheus |
| Official title | Effect of Extracorporeal Liver Support by MARS and Prometheus on Albumin-Bound Substances in Acute-on-Chronic Liver Failure |
| Lead sponsor | Medical University of Graz, Other |
| Collaborators | Fresenius Medical Care North America Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Liver Failure |
| Intervention type | Device |
| Interventions | MARS (Molecular Adsorbents Recirculating System), Prometheus (FPSA, Fractionated Plasma Separation and Adsorption) |
| Enrollment | 10 |
| Start date | Mar 1, 2003 |
| Completion | Apr 1, 2004 |
| First posted | Dec 4, 2006 |
| Last update posted | Dec 4, 2006 |
| Countries | Austria |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: